Company news

DexCom, Inc. news in 2026

DexCom, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Dexcom Reports Third Quarter 2026 Financial Results

October 29, 2026

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in November

October 28, 2026

Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin

October 14, 2026

Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4: 30 p.m. Eastern Time

October 7, 2026

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

October 6, 2026

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

September 28, 2026

Dexcom Promotes Jereme Sylvain to Chief Operating Officer

September 14, 2026

Dexcom Appoints Glenn Boehnlein to Board of Directors

September 10, 2026

Dexcom Reports Second Quarter 2026 Financial Results

July 29, 2026

Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program

July 22, 2026

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

July 13, 2026

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4: 30 p.m. Eastern Time

July 9, 2026

Dexcom Further Advances Vision of Glucose Biosensing for All

June 23, 2026

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

June 6, 2026

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026

June 3, 2026

Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience

June 2, 2026

Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users

May 26, 2026

Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

May 18, 2026

Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

May 13, 2026

Dexcom to Host Investor Day on May 14, 2026

May 5, 2026

Dexcom Reports First Quarter 2026 Financial Results

April 29, 2026

Middle East and Africa Continuous Glucose Monitoring Market Forecast and Company Analysis Report 2026-2034 Featuring Dexcom, Medtronic, Senseonics, Abbott Diabetes Care, and GlySens

April 29, 2026

Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4: 30 p.m. Eastern Time

April 1, 2026

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

March 10, 2026

Dexcom Appoints Rick Osterloh to Board of Directors

February 26, 2026

Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results

February 12, 2026

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

February 5, 2026

Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management

February 4, 2026

Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4: 30 p.m. Eastern Time.

January 27, 2026

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

January 12, 2026

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

January 6, 2026

Calls in 2026

Decks in 2026